[Invention Patent] [Invention Authorized Patent] A combination therapy for treating visual impairment and injury and relieving visual fatigue-CN201110098756.0 Valid patent
Applicant: Weihai Kangbo Er Biopharmaceutical Co., Ltd.; Second Artillery General Hospital of the Chinese People's Liberation Army
Application date: 2011-04-20 - Main classification number: A61K36/815
Abstract: A kind of A combination therapy for treating visual impairment and injury and relieving visual fatigue, using a combination of oral preparations, eye creams, and eye drops. Oral preparations use cassia seeds, chrysanthemums, wolfberry, rehmannia glutinosa, poria, and zinc gluconate as raw materials; eye creams use chrysanthemums, cassia seeds, Senecio japonica, Buddleia japonica, pearl powder, borneol, deoxyurscholic acid, and cream base as raw materials; The eye drops use seaweed, sea octopus, Cassia, vitamin B6, menthol, taurine, and sodium hyaluronate as raw materials. The oral preparations, eye creams and eye drops in the combination therapy series of this invention complement each other, provide the nutrients needed by the eyes, effectively remove free radicals and lipid peroxides, dissolve and absorb necrotic tissue and degenerated components, activate optic nerve cells, and adjust According to the functional status of the organs, the symptoms of the diseased tissue can be treated to restore local blood circulation, improve the function of the visual system, relieve visual fatigue and delay eye aging.